Affinity Asset Advisors, LLC Innate Pharma Sa Transaction History
Affinity Asset Advisors, LLC
- $896 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding IPHA
# of Institutions
10Shares Held
96.7KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY43.5KShares$91,4000.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il24.3KShares$50,9600.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny15.3KShares$32,1840.0% of portfolio
-
Ubs Group Ag9KShares$18,9020.0% of portfolio
-
Gamma Investing LLC Foster City, CA3.46KShares$7,2570.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $168M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...